← feed

Is NCT03226119 results overdue?

Yes — results are overdue. Primary completion was 2018-07-10; the FDAAA-801 reporting deadline (2019-07-10) passed 2629 days ago and no results are posted on ClinicalTrials.gov.

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

NCT IDNCT03226119 ↗
SponsorMP Biomedicals, LLC (INDUSTRY)
PhasePHASE4
StatusCOMPLETED
Primary completion2018-07-10 (ACTUAL)
Reporting deadline2019-07-10 (completion + 365d)
Days overdue2629
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: yes
ProvenanceFlagged overdue on 2026-09-19 · SHA-256 a3dec3c63b4f1ee4… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03226119. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →